APPY Share Price

Open 3.76 Change Price %
High 4.05 1 Day -0.01 -0.25
Low 3.56 1 Week 0.00 0.00
Close 3.94 1 Month 0.00 0.00
Volume 116276 1 Year 0.87 28.34
52 Week High 6.65
52 Week Low 2.14
APPY Important Levels
Resistance 2 4.39
Resistance 1 4.21
Pivot 3.85
Support 1 3.67
Support 2 3.49
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
SIRI 5.07 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
ESSX 0.22 69.23%
MYRX 0.08 60.00%
CGEI 0.35 59.09%
LOCM 0.09 50.00%
RITT 0.03 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CARV 4.90 22.81%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

AspenBio Pharma, Inc. (NASDAQ: APPY)

APPY Technical Analysis 4
As on 9th Dec 2016 APPY Share Price closed @ 3.94 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.52 & Buy for SHORT-TERM with Stoploss of 2.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
APPY Target for April
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
APPY Other Details
Segment EQ
Market Capital 20371508.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.venaxis.com
APPY Address
APPY
1585 South Perry Street
Castle Rock, CO 80104
United States
Phone: 303-794-2000
Fax: 303-798-8332
APPY Latest News
Bioptix, Inc. :BIOP Placed on Most Volatile List   Aiken Advocate   - 18th Apr 17
Bioptix names new CEO, receives notice of noncompliance from Nasdaq   BizWest Media   - 14th Apr 17
Form 8-K Bioptix, Inc. For: Apr 10   StreetInsider.com   - 14th Apr 17
Bioptix Announces Executive Leadership Change   PR Newswire (press release)   - 11th Apr 17
BRIEF-Bioptix Inc files for mixed shelf offering of up to $20 million - SEC filing   Reuters   - 09th Feb 17
Bioptix Announces Streamlining of Workforce   PR Newswire (press release)   - 21st Jan 17
4.13   MarketWatch   - 07th Jan 17
Bioptix Reports Board of Director Changes   PR Newswire (press release)   - 07th Jan 17
Honig Is Buying Again: This Time, Bioptix Inc. (NASDAQ:BIOP)   Small Cap Exclusive (press release)   - 06th Jan 17
Venaxis Announces Acquisition of BiOptix   PR Newswire (press release)   - 14th Sep 16
Interactive Technical Analysis Chart AspenBio Pharma, Inc. ( APPY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on AspenBio Pharma, Inc.
APPY Business Profile
Venaxis, Inc., formerly AspenBio Pharma, Inc., is focused on products that addresses unmet human diagnostic needs. The Company is developing a multi-marker blood test panel, APPY1, which is focused to be used by emergency department and urgent care physicians to aid them in the evaluation of possible appendicitis in children, adolescent and young adult patients (ages 2-20) that present with abdominal pain. As on December 31, 2012, the Company’s research and development activities are focused primarily on a human acute appendicitis blood-based test. APPY1 is a multi-marker blood test panel of biomarkers consisting of the Company’s patented MRP 8/14 (also known as S100A8/A9 or calprotectin) and C-reactive protein (CRP), along with White Blood Cell count (WBC). These results are displayed on the display screen and are also included on a patient print-out from the APPY reader, which is a small bioanalyzer (instrument or reader)